Key drug development trends and predictions for 2024
Drug Discovery World
FEBRUARY 19, 2024
However, despite these challenges, there are some positive developments; for instance, potential signs of improvement in the financial situation were flagged in late 2023 with AstraZeneca’s acquisition of cell therapy company Gracell for $1.2bn. antibody-drug conjugate [ADC] pipelines in some oncology settings).
Let's personalize your content